These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 32979508)

  • 61. Left atrial appendage morphology and thromboembolic risk after catheter ablation for atrial fibrillation.
    Nedios S; Kornej J; Koutalas E; Bertagnolli L; Kosiuk J; Rolf S; Arya A; Sommer P; Husser D; Hindricks G; Bollmann A
    Heart Rhythm; 2014 Dec; 11(12):2239-46. PubMed ID: 25128733
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Efficacy of catheter ablation in nonparoxysmal atrial fibrillation patients with severe enlarged left atrium and its impact on left atrial structural remodeling.
    Pump A; Di Biase L; Price J; Mohanty P; Bai R; Santangeli P; Mohanty S; Trivedi C; Yan RX; Horton R; Sanchez JE; Zagrodzky J; Bailey S; Gallinghouse GJ; Burkhardt JD; Natale A
    J Cardiovasc Electrophysiol; 2013 Nov; 24(11):1224-31. PubMed ID: 24020717
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The role of preprocedural monocyte-to-high-density lipoprotein ratio in prediction of atrial fibrillation recurrence after cryoballoon-based catheter ablation.
    Canpolat U; Aytemir K; Yorgun H; Şahiner L; Kaya EB; Çay S; Topaloğlu S; Aras D; Oto A
    Europace; 2015 Dec; 17(12):1807-15. PubMed ID: 25995388
    [TBL] [Abstract][Full Text] [Related]  

  • 64. CHA2DS2-VASc and SAMe-TT2R2 scores as predictors of recurrence for nonvalvular atrial fibrillation patients on vitamin K antagonists after radiofrequency catheter ablation.
    Zhao J; Zhou D; Chen M; Zhuo C; Lin Z; Zheng L; Wang Q
    J Cardiovasc Med (Hagerstown); 2020 Mar; 21(3):200-208. PubMed ID: 31977539
    [TBL] [Abstract][Full Text] [Related]  

  • 65. QTc interval predicts outcome of catheter ablation in paroxysmal atrial fibrillation patients with type 2 diabetes mellitus.
    Ma N; Wu XY; Ma CS; Liu N; Bai R; Du X; Ruan YF; Dong JZ
    J Huazhong Univ Sci Technolog Med Sci; 2016 Oct; 36(5):646-652. PubMed ID: 27752887
    [TBL] [Abstract][Full Text] [Related]  

  • 66. U-shaped association between serum free triiodothyronine and recurrence of atrial fibrillation after catheter ablation.
    Wei SB; Wang W; Liu N; Chen J; Guo XY; Tang RB; Yu RH; Long DY; Sang CH; Jiang CX; Li SN; Wen SN; Wu JH; Bai R; Du X; Dong JZ; Ma CS
    J Interv Card Electrophysiol; 2018 Apr; 51(3):263-270. PubMed ID: 29480346
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cost-effectiveness of the convergent procedure and catheter ablation for non-paroxysmal atrial fibrillation.
    Anderson LH; Black EJ; Civello KC; Martinson MS; Kress DC
    J Med Econ; 2014 Jul; 17(7):481-91. PubMed ID: 24693987
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Challenging Achievement of Bidirectional Block After Linear Ablation Affects the Rhythm Outcome in Patients With Persistent Atrial Fibrillation.
    Kim TH; Park J; Uhm JS; Kim JY; Joung B; Lee MH; Pak HN
    J Am Heart Assoc; 2016 Oct; 5(10):. PubMed ID: 27792644
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Atrial Fibrillation Ablation and Reduction of Stroke Events: Understanding the Paradoxical Lack of Evidence.
    Barra S; Narayanan K; Boveda S; Primo J; Gonçalves H; Baran J; Agarwal S; Marijon E; Providência R
    Stroke; 2019 Oct; 50(10):2970-2976. PubMed ID: 31510894
    [No Abstract]   [Full Text] [Related]  

  • 70. Catheter Ablation versus Thoracoscopic Surgical Ablation in Long Standing Persistent Atrial Fibrillation (CASA-AF): study protocol for a randomised controlled trial.
    Khan HR; Kralj-Hans I; Haldar S; Bahrami T; Clague J; De Souza A; Francis D; Hussain W; Jarman J; Jones DG; Mediratta N; Mohiaddin R; Salukhe T; Jones S; Lord J; Murphy C; Kelly J; Markides V; Gupta D; Wong T
    Trials; 2018 Feb; 19(1):117. PubMed ID: 29458408
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Impact of atrial fibrillation termination mode during catheter ablation procedure on maintenance of sinus rhythm.
    Faustino M; Pizzi C; Capuzzi D; Agricola T; Costa GM; Flacco ME; Marzuillo C; Nocciolini M; Capasso L; Manzoli L
    Heart Rhythm; 2014 Sep; 11(9):1528-35. PubMed ID: 24861448
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Comparative effectiveness of catheter ablation devices in the treatment of atrial fibrillation: a network meta-analysis.
    Gupta D; Potter T; Disher T; Eaton K; Goldstein L; Patel L; Grima D; Velleca M; Costa G
    J Comp Eff Res; 2020 Jan; 9(2):115-126. PubMed ID: 31913063
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Five-year impact of catheter ablation for atrial fibrillation in patients with a prior history of stroke.
    Bunch TJ; May HT; Bair TL; Crandall BG; Cutler MJ; Day JD; Jacobs V; Mallender C; Osborn JS; Weiss JP
    J Cardiovasc Electrophysiol; 2018 Feb; 29(2):221-226. PubMed ID: 29131434
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Incidence and outcomes of cerebrovascular events complicating catheter ablation for atrial fibrillation.
    Liu Y; Zhan X; Xue Y; Deng H; Fang X; Liao H; Huang J; Liu F; Liang Y; Wei W; Wu S
    Europace; 2016 Sep; 18(9):1357-65. PubMed ID: 26705560
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Comparison of phase mapping and electrogram-based driver mapping for catheter ablation in atrial fibrillation.
    Lin CY; Lin YJ; Narayan SM; Baykaner T; Lo MT; Chung FP; Chen YY; Chang SL; Lo LW; Hu YF; Liao JN; Tuan TC; Chao TF; Te ALD; Kuo L; Vicera JJB; Chang TY; Salim S; Chien KL; Chen SA
    Pacing Clin Electrophysiol; 2019 Feb; 42(2):216-223. PubMed ID: 30536679
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Safety and Clinical Outcomes of Catheter Ablation of Atrial Fibrillation in Patients With Chronic Kidney Disease.
    Ullal AJ; Kaiser DW; Fan J; Schmitt SK; Than CT; Winkelmayer WC; Heidenreich PA; Piccini JP; Perez MV; Wang PJ; Turakhia MP
    J Cardiovasc Electrophysiol; 2017 Jan; 28(1):39-48. PubMed ID: 27782345
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Catheter ablation of atrial fibrillation: state-of-the-art techniques and future perspectives.
    Santangeli P; Di Biase L; Burkhardt DJ; Horton R; Sanchez J; Bai R; Pump A; Perez M; Wang PJ; Natale A; Al-Ahmad A
    J Cardiovasc Med (Hagerstown); 2012 Feb; 13(2):108-24. PubMed ID: 22193837
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Catheter ablation of atrial fibrillation in patients with heart failure and preserved ejection fraction.
    Black-Maier E; Ren X; Steinberg BA; Green CL; Barnett AS; Rosa NS; Al-Khatib SM; Atwater BD; Daubert JP; Frazier-Mills C; Grant AO; Hegland DD; Jackson KP; Jackson LR; Koontz JI; Lewis RK; Sun AY; Thomas KL; Bahnson TD; Piccini JP
    Heart Rhythm; 2018 May; 15(5):651-657. PubMed ID: 29222043
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Oral anticoagulant therapy for stroke prevention in patients with atrial fibrillation undergoing ablation: results from the First European Snapshot Survey on Procedural Routines for Atrial Fibrillation Ablation (ESS-PRAFA).
    Potpara TS; Larsen TB; Deharo JC; Rossvoll O; Dagres N; Todd D; Pison L; Proclemer A; Purefellner H; Blomström-Lundqvist C;
    Europace; 2015 Jun; 17(6):986-93. PubMed ID: 26023177
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Benefit of left atrial appendage electrical isolation for persistent and long-standing persistent atrial fibrillation: a systematic review and meta-analysis.
    Romero J; Michaud GF; Avendano R; Briceño DF; Kumar S; Carlos Diaz J; Mohanty S; Trivedi C; Gianni C; Della Rocca D; Proietti R; Perrotta L; Bordignon S; Chun JKR; Schmidt B; Garcia M; Natale A; Di Biase L
    Europace; 2018 Aug; 20(8):1268-1278. PubMed ID: 29342299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.